1. Home
  2. ITCI vs GMED Comparison

ITCI vs GMED Comparison

Compare ITCI & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • GMED
  • Stock Information
  • Founded
  • ITCI 2002
  • GMED 2003
  • Country
  • ITCI United States
  • GMED United States
  • Employees
  • ITCI N/A
  • GMED N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • GMED Medical/Dental Instruments
  • Sector
  • ITCI Health Care
  • GMED Health Care
  • Exchange
  • ITCI Nasdaq
  • GMED Nasdaq
  • Market Cap
  • ITCI 8.0B
  • GMED 9.5B
  • IPO Year
  • ITCI N/A
  • GMED 2012
  • Fundamental
  • Price
  • ITCI $76.91
  • GMED $73.32
  • Analyst Decision
  • ITCI Strong Buy
  • GMED Buy
  • Analyst Count
  • ITCI 12
  • GMED 12
  • Target Price
  • ITCI $97.00
  • GMED $77.64
  • AVG Volume (30 Days)
  • ITCI 438.6K
  • GMED 676.7K
  • Earning Date
  • ITCI 10-30-2024
  • GMED 11-05-2024
  • Dividend Yield
  • ITCI N/A
  • GMED N/A
  • EPS Growth
  • ITCI N/A
  • GMED N/A
  • EPS
  • ITCI N/A
  • GMED 0.30
  • Revenue
  • ITCI $564,526,000.00
  • GMED $2,236,530,000.00
  • Revenue This Year
  • ITCI $46.60
  • GMED $61.37
  • Revenue Next Year
  • ITCI $37.06
  • GMED $7.07
  • P/E Ratio
  • ITCI N/A
  • GMED $240.68
  • Revenue Growth
  • ITCI 54.31
  • GMED 103.89
  • 52 Week Low
  • ITCI $45.50
  • GMED $43.39
  • 52 Week High
  • ITCI $84.89
  • GMED $75.98
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 57.52
  • GMED 59.17
  • Support Level
  • ITCI $71.95
  • GMED $71.93
  • Resistance Level
  • ITCI $79.46
  • GMED $75.98
  • Average True Range (ATR)
  • ITCI 1.79
  • GMED 1.40
  • MACD
  • ITCI 0.49
  • GMED 0.30
  • Stochastic Oscillator
  • ITCI 70.25
  • GMED 60.71

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

Share on Social Networks: